Regulation of interleukin-8 binding and function by heparin and α2- macroglobulin

Clinical and Experimental Allergy

Volumn 28, Issue 5, 1998, Pages 616-624

  Ramdin, L ^a   Perks, B ^a   Sheron, N ^a   Shute, J K ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

2 macroglobulin; Chemotaxis; Heparin; Interleukin 8; Interleukin 8 receptor; Neutrophil

Indexed keywords

ALPHA 2 MACROGLOBULIN; CYTOKINE; DEXTRAN SULFATE; HEPARAN SULFATE; HEPARIN DERIVATIVE; INTERLEUKIN 8; INTERLEUKIN 8 RECEPTOR; M 7151; UNCLASSIFIED DRUG;

ARTICLE; BIOASSAY; CELL MIGRATION; GEL FILTRATION CHROMATOGRAPHY; IMMUNE RESPONSE; IMMUNOBLOTTING; MAST CELL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN BINDING;

ALPHA-MACROGLOBULINS; ANTIGENS, CD; CHEMOTAXIS, LEUKOCYTE; CHROMATOGRAPHY, GEL; HEPARIN; HEPARITIN SULFATE; HUMANS; IMMUNOBLOTTING; INTERLEUKIN-8; NEUTROPHILS; PROTEIN BINDING; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-8A;

EID: 0031838620     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1998.00283.x     Document Type: Article

References (44)

1. Walker C, Bauer W, Braun RK et al. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 1994; 150:1038-48.
2. Nocker RET, van Schoonbrood DFM, de Graaf EA et al. Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 1996; 109:183-91.
3. Marini M, Vittori E, Hollemborg J, Mattoli S. Expression of the potent inflammatory cytokines, granulocyte-macrophage colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J Allery Clin Immunol 1992; 89:1001-9.
4. Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995; 95:843-52.
5. Warringa RAJ, Mengelers HJJ, Raaijmakers JAM, Bruijnzeel PLB, Koenderman L. Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma. J Allergy Clin Immunol 1993; 91:1198-205.
6. Kurashima K, Mukaida N, Fujimura M et al. Increase of chemokine levels in sputum precedes exacerbation of acute asthma attacks. J Leukoc Biol 1996; 59:313-6.
7. Broide DH, Gleich GJ, Cuomo AJ et al. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol 1991; 88:637-48.
8. Lasser EC, Simon RA, Lyon SG, Hamblin AE, Stein R. Heparin-like anticoagulants in asthma. Allergy 1987; 42:619-25.
9. Górski A, Wasik M, Nowaczyk M, Korczak-Kowalska G. Immunomodulating activity of heparin. FASEB J 1991; 5:2287-91.
10. Tyrrell DJ, Kilfeather S, Page CP. Therapeutic uses of heparin beyond its traditional role as an anticoagulant. TiPS 1995; 16:198-204.
11. Bowler SD, Smith SM, Lavercombe PS. Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects. Am Rev Respir Dis 1993; 147:160-3.
12. Diamant Z, Timmers MC, van der Veen H et al. Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma. Am J Respir Crit Care Med 1996; 153:1790-5.
13. Garrigo J, Danta I, Ahmed T. Time course of the protective effect of inhaled heparin on exercise-induced asthma. Am J Respir Crit Care Med 1996; 153:1702-7.
14. Miller MD, Krangel MS. Biology and biochemistry of the chemokines: A family of chemotactic and inflammatory cytokines. Crit Rev Immunol 1992; 12:17-46.
15. Webb LMC, Ehrengruber MU, Clark-Lewis I, Baggiolini M, Rot A. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. %Proc Natl Acad Sci USA 1993; 90:7158-62.
16. 2-macroglobulin. Immunol Today 1990; 11:163-6.
17. Perks B, Hillaby CH, Warner JO, Shute JK. Macromolecular forms of chemokines in the airways in asthma and cystic fibrosis. Resp Med 1997; 91:A43.
18. Dai Y, Dean TP, Church MK, Warner JO, Shute JK. Desensitisation of neutrophil responses by systemic interleukin-8 in cystic fibrosis. Thorax 1994; 49:867-71.
19. Wrenshall LE, Cerra FB, Singh RK, Platt JL. Heparan sulfate initiates signals in murine macrophages leading to divergent biologic outcomes. J Immunol 1995; 154:871-80.
20. Rot A, Hub E, Middleton J et al. Some aspects of IL-8 pathophysiology III. chemokine interaction with endothelial cells. J Leukoc Biol 1996; 59:39-44.
21. Ramdin L, Sheron N, Dean T, Shute JK. An immunocytochemical study of IL-8 and heparan sulphate expression in the lung in cystic fibrosis. Eur Resp J 1995; 8:576s.
22. Rot A. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol Today 1992; 13:291-4.
23. Tanaka Y, Adams DH, Shaw S. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today 1993; 14:111-5.
24. Salmivirta M, Lidholt K, Lindahl U. Heparan sulfate: a piece of information. FASEB J 1996; 10:1270-9.
25. Witt DP, Lander AD. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr Biol 1994; 4:394-400.
26. Levine SP, Sorenson RR, Harris MA, Knieriem LK. The effect of platelet factor 4 (PF4) on assays of plasma heparin. Br J Haematol 1984; 57:585-96.
27. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139:806-17.
28. San Antonio JD, Slover J, Lawler J, Karnovsky MJ, Lander AD. Specificity of the interactions of extracellular matrix proteins with subpopulations of the glycosaminoglycan heparin. Biochem 1993; 32:4746-55.
29. Green WF, Konnaris K, Woolcock AJ. Effect of salbutamol, fenoterol, and sodium cromoglycate on the release of heparin from sensitized human lung fragments challenged with dermatophagoides pteronyssinus allergen. Am J Respir Cell Mol Biol 1993; 8:518-21.
30. 15 of interleukin-8 in the high affinity interaction with the interleukin-8 receptor type A. J Biol Chem 1995; 270:10428-31.
31. McCaffrey TA, Falcone DJ, Du B. Transforming growth factor-β1 is a heparin-binding protein: Identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-β1. J Cell Physiol 1992; 152:430-40.
32. 2-macroglobulin and tryptase in allergic rhinitis. J Allergy Clin Immunol 1995; 96:97-103.
33. Samanta AK, Oppenheim JJ, Matsushina K. Interleukin-8 (monocyte-derived neutrophil chemotactic factor) dynamically regulates its own receptor expression on human neutrophils. J Biol Chem 1990; 265:183-9.
34. 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissue. Cell Tissue Res 1992; 269:375-85.
35. Nelson RM, Cecconi O, Roberts WG, Aruffo A, Linhardt RJ, Bevilacqua MP. Heparin oligosaccharides bind L-and P-selectin and inhibit acute inflammation. Blood 1993; 82:3253-8.
36. Yang L, Yang Y-C. Heparin inhibits the expression of interleukin-11 and granulocyte-macrophage colony-stimulating factor in primate bone marrow stromal fibroblasts through mRNA destabilization. Blood 1995; 86:2526-33.
37. Høgåsen AKM, Abrahamsen TG. Heparin suppresses lipopolysaccharide-induced monocyte production of several cytokines, but simultaneously stimulates C3 production. Thrombosis Res 1995; 80:179-84.
38. + T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored RANTES and MIP-1β. J Immunol 1994; 153:4899-906.
39. Bashkin P, Doctrow S, Klagsbrun M et al. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochem 1989; 28:1737-43.
40. Cockwell P, Adams DH, Savage COS. Glycosaminoglycans contribute to multiple functions of vascular endothelial cells. Clin Exp Immunol 1996; 104:1-3.
41. Rix DA, Douglas MS, Talbot D, Dark JH, Kirby JA. Role of glycosaminoglycans (GAGs) in regulation of the immunogenicity of human vascular endothelial cells. Clin Exp Immunol 1996; 104:60-5.
42. Page CP. An explanation of the asthma paradox. Am Rev Respir Dis 1993; 147:S29-S32.
43. Dawes J. What happens to heparin? Today's Life Science 1990; 26-9.
44. Watson CA, Camera-Benson L, Palmer-Crocker R, Pober JS. Variability among human umbilical vein endothelial cultures. Sci 1995; 268:447-8.